Intensified ABVD Bests PET-Adapted ABVD as First-Line Therapy for Hodgkin Lymphoma

Intensified ABVD can improve outcomes vs PET-adapted ABVD in previously untreated Hodgkin lymphoma, a phase 3 study suggests.

Related Keywords

Italy ,Istituto Nazionale Tumori ,Antonio Pinto ,Fondazioneg Pascale ,International Conference On Malignant Lymphoma ,International Conference ,Malignant Lymphoma ,